293 related articles for article (PubMed ID: 17161379)
1. Effects of statin treatment and withdrawal on angiotensin II-induced phosphorylation of p38 MAPK and ERK1/2 in cultured vascular smooth muscle cells.
Tristano AG; Castejon AM; Castro A; Cubeddu LX
Biochem Biophys Res Commun; 2007 Feb; 353(1):11-7. PubMed ID: 17161379
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of angiotensin II-AT1 receptors during statin withdrawal in vascular smooth muscle cells.
Castejon AM; Zollner E; Tristano AG; Cubeddu LX
J Cardiovasc Pharmacol; 2007 Dec; 50(6):708-11. PubMed ID: 18091590
[TBL] [Abstract][Full Text] [Related]
3. Responses of vascular smooth muscle cells to estrogen are dependent on balance between ERK and p38 MAPK pathway activities.
Cheng B; Song J; Zou Y; Wang Q; Lei Y; Zhu C; Hu C
Int J Cardiol; 2009 May; 134(3):356-65. PubMed ID: 18584900
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of ERK1/2 and p38(MAPK) by components of the Rho signaling pathway during sphingosine-1-phosphate-induced smooth muscle cell migration.
Galaria II; Fegley AJ; Nicholl SM; Roztocil E; Davies MG
J Surg Res; 2004 Dec; 122(2):173-9. PubMed ID: 15555614
[TBL] [Abstract][Full Text] [Related]
5. Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin.
González-Díez M; Rodríguez C; Badimon L; Martínez-González J
Thromb Haemost; 2008 Jul; 100(1):119-26. PubMed ID: 18612546
[TBL] [Abstract][Full Text] [Related]
6. Withdrawal of cerivastatin induces monocyte chemoattractant protein 1 and tissue factor expression in cultured vascular smooth muscle cells.
Brandes RP; Beer S; Ha T; Busse R
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1794-800. PubMed ID: 12933532
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of smooth muscle cell calcium mobilization and aortic ring contraction by lactone vastatins.
Escobales N; Crespo MJ; Altieri PI; Furilla RA
J Hypertens; 1996 Jan; 14(1):115-21. PubMed ID: 12013483
[TBL] [Abstract][Full Text] [Related]
8. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway.
Yoshizumi M; Tsuchiya K; Suzaki Y; Kirima K; Kyaw M; Moon JH; Terao J; Tamaki T
Biochem Biophys Res Commun; 2002 May; 293(5):1458-65. PubMed ID: 12054679
[TBL] [Abstract][Full Text] [Related]
9. Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation.
Kyaw M; Yoshizumi M; Tsuchiya K; Kagami S; Izawa Y; Fujita Y; Ali N; Kanematsu Y; Toida K; Ishimura K; Tamaki T
Mol Pharmacol; 2004 Apr; 65(4):832-41. PubMed ID: 15044612
[TBL] [Abstract][Full Text] [Related]
10. Fluvastatin prevents vascular hyperplasia by inhibiting phenotype modulation and proliferation through extracellular signal-regulated kinase 1 and 2 and p38 mitogen-activated protein kinase inactivation in organ-cultured artery.
Sakamoto K; Murata T; Chuma H; Hori M; Ozaki H
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):327-33. PubMed ID: 15591221
[TBL] [Abstract][Full Text] [Related]
11. A therapeutic dose of the lipophilic statin pitavastatin enhances oxidant-induced apoptosis in human vascular smooth muscle cells.
Tsujimoto A; Takemura G; Mikami A; Aoyama T; Ohno T; Maruyama R; Nakagawa M; Minatoguchi S; Fujiwara H
J Cardiovasc Pharmacol; 2006 Oct; 48(4):160-5. PubMed ID: 17086094
[TBL] [Abstract][Full Text] [Related]
12. Acetoacetate activation of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in primary cultured rat hepatocytes: role of oxidative stress.
Abdelmegeed MA; Kim SK; Woodcroft KJ; Novak RF
J Pharmacol Exp Ther; 2004 Aug; 310(2):728-36. PubMed ID: 15051799
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional down-regulation of thromboxane A(2) receptor expression via activation of MAPK ERK1/2, p38/NF-kappaB pathways.
Zhang W; Zhang Y; Edvinsson L; Xu CB
J Vasc Res; 2009; 46(2):162-74. PubMed ID: 18769070
[TBL] [Abstract][Full Text] [Related]
14. Nobiletin, a dietary phytochemical, inhibits vascular smooth muscle cells proliferation via calcium-mediated c-Jun N-terminal kinases pathway.
Zhou CH; Wu XH; Wu YQ
Eur J Pharmacol; 2009 Aug; 615(1-3):55-60. PubMed ID: 19486902
[TBL] [Abstract][Full Text] [Related]
15. Functional coupling expression of COX-2 and cPLA2 induced by ATP in rat vascular smooth muscle cells: role of ERK1/2, p38 MAPK, and NF-kappaB.
Lin CC; Lin WN; Wang WJ; Sun CC; Tung WH; Wang HH; Yang CM
Cardiovasc Res; 2009 Jun; 82(3):522-31. PubMed ID: 19233864
[TBL] [Abstract][Full Text] [Related]
16. Functionally opposing roles of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in the regulation of cardiac contractility.
Szokodi I; Kerkelä R; Kubin AM; Sármán B; Pikkarainen S; Kónyi A; Horváth IG; Papp L; Tóth M; Skoumal R; Ruskoaho H
Circulation; 2008 Oct; 118(16):1651-8. PubMed ID: 18824646
[TBL] [Abstract][Full Text] [Related]
17. Exposure of C6 glioma cells to Pb(II) increases the phosphorylation of p38(MAPK) and JNK1/2 but not of ERK1/2.
Posser T; de Aguiar CB; Garcez RC; Rossi FM; Oliveira CS; Trentin AG; Neto VM; Leal RB
Arch Toxicol; 2007 Jun; 81(6):407-14. PubMed ID: 17333127
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells.
Liang KC; Lee CW; Lin WN; Lin CC; Wu CB; Luo SF; Yang CM
J Cell Physiol; 2007 Jun; 211(3):759-70. PubMed ID: 17311279
[TBL] [Abstract][Full Text] [Related]
19. Nuclear accumulation of the AT1 receptor in a rat vascular smooth muscle cell line: effects upon signal transduction and cellular proliferation.
Cook JL; Mills SJ; Naquin R; Alam J; Re RN
J Mol Cell Cardiol; 2006 May; 40(5):696-707. PubMed ID: 16516913
[TBL] [Abstract][Full Text] [Related]
20. Xanthine oxidase-derived extracellular superoxide anions stimulate activator protein 1 activity and hypertrophy in human vascular smooth muscle via c-Jun N-terminal kinase and p38 mitogen-activated protein kinases.
Matesanz N; Lafuente N; Azcutia V; Martín D; Cuadrado A; Nevado J; Rodríguez-Mañas L; Sánchez-Ferrer CF; Peiró C
J Hypertens; 2007 Mar; 25(3):609-18. PubMed ID: 17278978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
